Danyll Foix Speaks at National Antitrust Enforcement Conference

News / October 13, 2017

Partner Danyll Foix will be a speaker at the 11th Annual Private Enforcement Conference of the American Antitrust Institute on Nov. 7, 2017, in Washington, D.C. Foix will join a panel discussion of “Agriculture Antitrust Class Actions.”

More information.

Related Services


In The Blogs

Previous Next
Antitrust Advocate
DOJ Now Targeting HR Professionals for Criminal Antitrust Violations
By Tyson Y. Herrold, Carl W. Hittinger
April 9, 2018
Partner Carl Hittinger and Associate Tyson Herrold authored an article published by The Legal Intelligencer on March 30, 2018. The article, “DOJ Now Targeting HR Professionals for Criminal Antitrust Violations,” examines the Department of...
Antitrust Advocate
The Department of Justice Weighs In on the Application of North Carolina Dental Examiners to the Florida State Bar
By William DeVinney
March 23, 2018
The Department of Justice (DOJ) recently took the uncommon step of submitting an amicus brief to weigh in on a motion to dismiss. TIKD Services, LLC v. The Florida Bar, No. 1:17-cv-24103 (S.D. Fla. filed Nov. 8, 2017), Dkt. 115...
Antitrust Advocate
Should a Judge’s Personal Judicial Experience Affect Antitrust Pleadings?
March 19, 2018
When the U.S. Supreme Court scrapped Conley v. Gibson’s “no set of facts” federal pleading standard in Twombly (2007) and Iqbal (2009), courts initially struggled to apply the inherently ambiguous “plausibility” standard. In the immediate...
Antitrust Advocate
Join Us for a Teleconference on New ABA Publication, “Antitrust Class Actions Handbook”
February 20, 2018
The ABA recently released a new publication that should be of interest to antitrust practitioners, the Antitrust Class Actions Handbook, Second Edition. The Handbook comprehensively addresses issues that arise before, during and after the...
Antitrust Advocate
No Health Care Merger Too Small for the FTC to Take an Antitrust Look
February 12, 2018
In our November and December 2016 articles, we discussed the Federal Trade Commission’s proclivity to challenge health care mergers, even when the purported anticompetitive effects of the relatively economically limited merger would be...